MDLN · CUSIP 58507V107
MEDLINE INC
Reported by 4 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 4
- Average portfolio weight
- 3.2%
- Combined reported value
- $1.8B
- Research group
- 79
4 of the 79 superinvestors Shameless Cloning tracks reported MEDLINE INC (MDLN) in their Q2 2026 13F filings, worth $1.8B combined, at an average 3.2% of their portfolios. The largest positions by portfolio weight belong to John Armitage (6.3%), Stephen Mandel (5.1%), Henry Ellenbogen (1.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| John ArmitageEgerton Capital (UK) LLP | 6.3% | $649.6M |
| Stephen MandelLONE PINE CAPITAL LLC | 5.1% | $827.0M |
| Henry EllenbogenDurable Capital Partners LP | 1.0% | $103.6M |
| Viking Global InvestorsVIKING GLOBAL INVESTORS LP | 0.5% | $190.9M |